AzTrials
AzTrials

PrediabetesBALANCENCT07478263

Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes

A study testing Regulation of Cues in people with Prediabetes and Obesity (Body Mass Index >30 kg/m2), run by University of California, San Diego at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Adapt the Regulation of Cues (ROC) treatment program for Latinas to see if it can treat prediabetes and prevent developing of Type 2 Diabetes and reduce weight. Read more about this study

Who is it for?
Ages 18 to 55 years, women only
What is being tested?
Regulation of Cues
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
31 Mar 2026to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women who self-identify as Hispanic/Latina, aged 18-55
  • BMI 30-45 kg/m2
  • Documented diagnosis of prediabetes also confirmed by HBA1c level of 5.7-6.4%
  • Spanish or English proficiency at a 5th grade level
  • Physician approval to participate

Who cannot join

  • Current diagnosis of T2D
  • Current Pregnancy or lactation or planning to get pregnant within the study duration
  • Recent history of heart disease, symptoms of angina, stroke, orthopedic problems that would limit activity during the following 6 months, or any other serious medical condition that would make physical activity unsafe
  • Currently enrolled in weight-loss program or taking medications for weight loss or prediabetes
  • Current moderate or severe alcohol or substance use disorder, acute suicidal ideation, psychosis, compensatory behaviors, or a diagnosis of bulimia
  • Hospitalization due to a psychiatric disorder in the past year.
  • Planning to move from the San Diego area within the next 6 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • UCSD Center for Healthy Eating and Activity Research (CHEAR

    La Jolla, California, 92093

    Dawn Eichen, PhD, 858-249-1123, deichen@health.ucsd.edu

    Recruiting

Other trials in United States

About this study

Official title: Reducing Obesity and Risk for Type 2 Diabetes in Latinas Using a Novel Behavioral Strategy Addressing Appetitive Traits

Adapt the Regulation of Cues (ROC) treatment program for Latinas to see if it can treat prediabetes and prevent developing of Type 2 Diabetes and reduce weight.

Being tested
Regulation of Cues
Medical subject headings
Prediabetic State, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Regulation of CuesBehavioural

    ROC includes appetite awareness training and cue-exposure treatment adapted particularly for Latinas with prediabetes.

Study groups in NCT07478263
Study groupRoleWhat they receive
Regulation of Cues (ROC)ExperimentalROC includes appetite awareness training and cue-exposure treatment adapted particularly for Latinas with prediabetes.
Receives: Behavioral: Regulation of Cues

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participant rating of whether the treatment was helpful

    Participants rating of acceptability of the treatment via questionnaire with item on a 5-point likert scale indicating ranked from 1 - strongly disagree to 5 - strongly agree that the treatment was helpful - higher values equal greater acceptability of treatment

    Measured: Following all 14 treatment sessions ~4 months after the start of treatment

  2. Attendance at Treatment Sessions

    Number of sessions attended out of the 14 treatment sessions

    Measured: During the four months/14 sessions of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2026
  2. Study start31 Mar 2026 (estimated)
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Regulation of Cues treatment includes appetite awareness training and cue-exposure treatment.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07478263
Sponsor's protocol ID
812688
Other IDs
P50MD017344
Acronym
BALANCE
Status last verified
Mar 2026
First submitted
10 Mar 2026
Last updated
17 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Regulation of Cues in people with Prediabetes and Obesity (Body Mass Index >30 kg/m2), run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participant rating of whether the treatment was helpful (time frame: Following all 14 treatment sessions ~4 months after the start of treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in